1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Facts recognized;

A. On March 31, 2009, the Plaintiff entered into an insurance contract with the Defendant listed in the separate sheet (hereinafter “instant insurance contract”).

B. At the time, the Defendant subscribed to a special agreement on cancer diagnosis expenses (the purchase amount of KRW 10 million; hereinafter “instant special agreement”), and the main contents are as follows.

1. Damage guaranteed (1) If the insured stated in a certificate of insurance coverage becomes final and conclusive after the date of commencement of coverage during the cover period of this Special Terms and Conditions, the company shall pay the following amounts in accordance with this Special Terms and Conditions:

25% or more of the purchase amount of the purchase amount of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the

2. The definitions and diagnosis determination of cancer, other skin cancer and Athram cancer. ① In this Special Terms and Conditions, cancer means the disease specified in the Table 7 (See Attached Table 7; hereinafter the same shall apply) of malicious life classification table.

3. In this special terms and conditions, the term “Athythythum cancer” means a disease falling under the classification number C73 of the classification table of malicious life.

(4) The diagnosis and confirmation of “Canceance,” “other skin cancer,” and “Athyrance cancer” shall be conducted by a person with a professional doctor’s license of an autopsy pathology or clinical pathology, and the diagnosis shall be based on organizational inspection, sacrine resistant examination, or opinion of absence regarding blood examination.

However, if it is not possible to conduct the above-mentioned pathological diagnosis, the clinical diagnosis of the above-mentioned celebrite, “other skin cancer”, and “Athrchite cancer” is recognized as evidence of “Archite”, “other skin cancer”, and “Athrchite cancer”.

In such cases, the insured shall be "c.", "other skin cancer" and "p.m."